Bacterial vaginosis (BV) is a bacterial infection caused by the overgrowth of bacteria in the vagina. It’s very common — in fact, it’s estimated that up to 1 in 3 women will have BV in their lifetime. This infection is also likely to recur, as research indicates that around 50% of women who have a BV infection will have a recurrent case of BV within six (6) months of their initial diagnosis.
Unfortunately, researchers don’t know exactly what causes the overgrowth of bacteria in the vagina that becomes BV — or why some people are more prone to get it than others. There is some correlation to sexual activity and the bacterium Gardnerella vaginalis, though. Other potential related bacteria include Lactobacillus, Prevotella, and Streptococcus viridans, among others1.
Common symptoms of BV include a fishy odor, elevated vaginal pH, itching, burning while urinating and a thin, greyish/white discharge. Traditional remedies for BV include oral antibiotics, antibiotic suppositories, or boric acid suppositories.
Since BV is common and likely to recur, it’s important to have treatment and symptom management options outside of oral antibiotics and antibiotic suppositories.*
FemiClear® BV in Vitro Testing
Here at FemiClear, we developed a new over-the-counter product for BV and tested it in an accredited laboratory.
In a four-hour time kill study, we’re proud to say that our product resulted in a 99.9% reduction in G. vaginalis*.
FemiClear® BV in Vivo Testing
The same FemiClear Bacterial Vaginosis (BV) Symptoms product was tested in more than 100 participants in the USA over the course of 2 –10 days starting in March 2022. Each participant (who had an active BV infection when they used the product) completed an online self-assessment evaluation survey**.
- 95% of participants reported the product effectively treated their BV infection**
- 86% of participants reported symptom relief within 24 hours of beginning use of the product**
- 86% of participants reported elimination of fishy odor**
- 92% of participants reported elimination of grayish/white discharge**
- 94% of participants reported significantly reduced symptoms within 2 days of beginning use of the product**
- 97% of participants reported liking the consistency and texture of the product**
- 90% of participants reported that they would recommend using the product**
The results of the FemiClear BV testing showed a large reduction in G. vaginalis under controlled laboratory conditions. Additional testing showed the product was effective in reducing various BV symptoms in the study population.
We’re proud to offer a new over-the-counter product for the treatment of BV infections, one that’s proven to reduce both the bacteria that causes BV and the symptoms associated with it.
Claims based on clinical and/or in vitro laboratory (non-human, non-animal) studies, and traditional homeopathic practice (not accepted medical evidence; not FDA evaluated). These statements have not been evaluated by the Food and Drug Administration. This product in not intended to diagnose, treat, cure,
*An independent accredited lab performed an in vitro (non-human/non-animal) time kill study to measure the amount Gardnerella Vaginalis that was killed. An overgrowth of Gardnerella Vaginalis, can cause a bacterial vaginosis (BV) infection, but might not be the only cause. Data on file.
**As self-reported in a comprehensive IRB approved study of >100 women. Individual results may vary. Data on file.